Early human B cell signatures of the primary antibody response to mRNA vaccination

Messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective at inducing protective immunity. However, weak antibody responses are seen in some individuals, and cellular correlates of immunity remain poorly defined, especially for B cells. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Kardava, Lela, Rachmaninoff, Nicholas, Lau, William W., Buckner, Clarisa M., Trihemasava, Krittin, Blazkova, Jana, Lopes de Assis, Felipe, Wang, Wei, Zhang, Xiaozhen, Wang, Yimeng, Chiang, Chi-I, Narpala, Sandeep, McCormack, Genevieve E., Liu, Can, Seamon, Catherine A., Sneller, Michael C., O’Connell, Sarah, Li, Yuxing, McDermott, Adrian B., Chun, Tae-Wook, Fauci, Anthony S., Tsang, John S., Moir, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282446/
https://www.ncbi.nlm.nih.gov/pubmed/35759653
http://dx.doi.org/10.1073/pnas.2204607119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282446/
https://www.ncbi.nlm.nih.gov/pubmed/35759653
http://dx.doi.org/10.1073/pnas.2204607119

Ejemplares similares